Evaluation of Belzutifan in Patients with Tumors Associated with Von Hippel-Lindau Disease: A Retrospective Analysis from a Single Center - Quiz - MDSpire

Evaluation of Belzutifan in Patients with Tumors Associated with Von Hippel-Lindau Disease: A Retrospective Analysis from a Single Center

  • By

  • Kilian Rhein

  • Fruzsina Kotsis

  • Athina Ganner

  • Sophie Astheimer

  • Christine Julia Gizaw

  • Yannik Laich

  • Cordula Annette Jilg

  • Jan-Helge Klingler

  • Elke Neumann-Haefelin

  • November 1, 2025

  • 0 min

Share

Original Source(s)

Evaluation of Belzutifan in Patients with Tumors Associated with Von Hippel-Lindau Disease: A Retrospective Analysis from a Single Center

  • by Kilian Rhein, Fruzsina Kotsis, Athina Ganner, Sophie Astheimer, Christine Julia Gizaw, Yannik Laich, Cordula Annette Jilg, Jan-Helge Klingler, Elke Neumann-Haefelin

  • November 1, 2025

Related Content

Pheochromocytoma complicated with acute myocardial infarction and cerebral infarction: a case report

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy

One Pathway for Esophageal Cancer?

Molecular profiling reveals precursor signals in BE-negative esophageal cancer

  • May 7, 2026

  • 2 min